Credit Suisse Starts Progenics Pharmaceuticals (PGNX) at Outperform
Tweet Send to a Friend
Credit Suisse initiates coverage on Progenics Pharmaceuticals (NASDAQ: PGNX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
